Submit Your Science to THT® 2027!

Transform the Future of Heart Failure Treatment

Submit your groundbreaking science for an opportunity to present on a global stage and earn a place among the prestigious faculty. Connect with a world-class network of experts, showcase your work alongside the brightest minds, and drive the future of heart failure care!

Submission Deadlines

Add these dates to your calendar

Scientific
Abstracts

Fellows
Challenging
Cases

Fellows
Abstract
Competition

Shock
Tank

Late-Breaking Clinical Trials &
Science / First-in-Human &
Early Feasibility Studies

THT® Shark Tank
Innovation
Competition

Early
Notification
Deadline

Submit early and get
a decision sooner

Thursday
Oct 1, 2026

Thursday
Oct 1, 2026

Thursday
Oct 1, 2026

—

Not applicable

—

Not applicable

—

Not applicable

Regular
Deadline

Final deadline
to submit

Monday
Nov 16, 2026

ADD TO CALENDAR

Monday
Nov 16, 2026

ADD TO CALENDAR

Monday
Nov 16, 2026

ADD TO CALENDAR

Monday
Nov 16, 2026

ADD TO CALENDAR

Tuesday
Dec 1, 2026

ADD TO CALENDAR

Tuesday
Dec 1, 2026

ADD TO CALENDAR

Submission portal closes at 2:00 PM Eastern Time.
For the October 1 early notification deadline, the time is EDT (UTC -4).
For the regular deadlines, the time is EST (UTC -5).

Questions?

Email us at [email protected].


Submission Categories and Guidelines

Scientific Abstracts

Submit your scientific abstracts of original research for the opportunity to present to thousands of your colleagues worldwide. Research can be in the form of clinical studies, basic science investigations, or preclinical studies and must be relevant to heart failure. Your abstracts must convey original research but can include portions of previous abstracts and/or manuscripts presented elsewhere. The top scored scientific abstracts will be published in JACC: Heart Failure.

Note About Submission Categories 
Submit single-patient case reports to Challenging Cases, regardless of the novelty of the case.


Fellows Challenging Cases

Submit your most challenging cases in heart failure. The THT directors will carefully review each submitted case, and the best will be selected for presentation. Top cases will be featured in TCTMD®.

Eligibility 
All current fellows (cardiology, heart failure, surgery, intensive care, etc.), interns, residents, medical students, and other professionals in other stages of training at the time of THT are welcome to submit challenging heart failure management cases.


Fellows Abstract Competition

Submit clinical studies, basic science investigations, or preclinical studies relevant to some aspect of heart failure, including diagnosis, therapy, or monitoring. Case reports or case series may be submitted for consideration under Fellows Challenging Cases. Competition winner will be announced in the Main Arena!

Eligibility 
All current fellows (cardiology, heart failure, surgery, intensive care, etc.), interns, residents, medical students, and other professionals in other stages of training at the time of THT are welcome to submit abstracts. The author submitting the abstract should have contributed substantially to the study, and this will be a major part of the grading.

Selection and Presentation

  • The five highest-rated submissions will be named as finalists.
  • Finalists will deliver an oral presentation during a dedicated fellows research session.
  • The five finalist presentations will be evaluated by an expert panel that will select the winning abstract.
  • Finalist will be interviewed and featured on TCTMD®.

Shock Tank

Submit your novel ideas for clinical study designs or registry studies to meaningfully advance the care of patients presenting with cardiogenic shock (due to acute myocardial infarction, decompensated chronic heart failure, or other causes).


Late-Breaking Clinical Science / First-In-Human and Early Feasibility Studies

Submit your late-breaking clinical science and first-in-human early feasibility studies. These are typically:

  • Primary or important secondary endpoint results of prospective, randomized clinical trials
  • First-time presentations of first-in-human experiences with novel devices or drugs
  • Results of pilot studies of drugs or novel devices
  • Large-scale, impactful single/multicenter registries

Please note that the following rarely qualify as late-breaking clinical science submissions and, instead, should be submitted as abstracts: preclinical studies, early first-in-human device studies, and meta-analyses.

Embargo 
Accepted late-breaking science and first-in-human early feasibility studies are strictly embargoed until time of presentation.


THT® Shark Tank Innovation Competition

Enter the THT® Shark Tank! Submit your concept-stage novel technologies in heart failure for a chance to present to a panel of expert judges. Finalists in the THT Shark Tank Innovation Competition, may be invited to submit brief reports and or a full paper to JCF; any such invitation will be non-exclusive and will not require a submission fee.

Your submission must be relevant to technology for the monitoring, diagnosis, or treatment of heart failure and address all the following:

  • Unmet clinical need/field of use
  • Technology differentiation and competitive landscape
  • IP position/landscape
  • Summary of preclinical and/or first-in-human data
  • Regulatory pathway/strategy and commercialization strategy

Frequently Asked Questions